S. 272 · Passed Senate · Health

Protect Infant Formula from Contamination Act

What it does

Infant formula manufacturers must report to the FDA within one business day if formula they processed but no longer control may lack required nutrients or be adulterated or misbranded.
Manufacturers must notify the FDA within one business day if testing reveals specified microorganisms (e.g., salmonella) in finished infant formula.
Manufacturers must promptly provide test results to the FDA and consult with the FDA on isolation and disposal of affected product.
The FDA must respond to contamination notifications and begin discussing investigative and corrective action with the manufacturer within one business day.

Official summary

Protect Infant Formula from Contamination Act This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day…

Latest action

May 4, 2026: Held at the desk.

Committee: Senate Health, Education, Labor, and Pensions